Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 61 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 91,100.0 | $6.8M | 0.64% | +500.0 | +0.6% | $74.48 | -12.5% |
| 62 | KURA | KURA ONCOLOGY INC | Healthcare | 591,500.0 | $6.5M | 0.61% | +320K | +117.9% | $10.97 | -1.3% |
| 63 | PODD | INSULET CORP | Healthcare | 42,000.0 | $6.4M | 0.60% | +28K | +200.0% | $152.25 | -10.2% |
| 64 | ERAS | ERASCA INC | Healthcare | 349,000.0 | $6.4M | 0.60% | NEW | — | $18.32 | -21.3% |
| 65 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 16,325.0 | $6.1M | 0.57% | -350.0 | -2.1% | $371.67 | -7.8% |
| 66 | STVN | STEVANATO GROUP S P A | Healthcare | 305,972.0 | $5.5M | 0.52% | +31K | +11.4% | $18.07 | +16.0% |
| 67 | — | ASTRANA HEALTH INC | — | 118,888.0 | $5.5M | 0.52% | NEW | — | $46.41 | — |
| 68 | CAH | CARDINAL HEALTH INC | Healthcare | 22,500.0 | $5.3M | 0.51% | -4K | -16.7% | $237.56 | -7.2% |
| 69 | ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | 17,200.0 | $5.2M | 0.49% | -17K | -50.1% | $301.03 | -16.1% |
| 70 | MOH | MOLINA HEALTHCARE INC | Healthcare | 21,857.0 | $5.0M | 0.47% | NEW | — | $228.70 | -15.1% |
| 71 | VKTX | VIKING THERAPEUTICS INC | Healthcare | 128,000.0 | $5.0M | 0.47% | -32K | -20.0% | $39.01 | -8.3% |
| 72 | CI | THE CIGNA GROUP | Healthcare | 17,400.0 | $4.8M | 0.45% | +9K | +117.5% | $275.68 | -2.5% |
| 73 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 59,900.0 | $4.7M | 0.45% | -33K | -35.5% | $79.29 | -43.7% |
| 74 | AMN | AMN HEALTHCARE SVCS INC | Healthcare | 144,466.0 | $4.7M | 0.44% | NEW | — | $32.37 | +7.1% |
| 75 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 179,000.0 | $4.6M | 0.43% | -20K | -10.1% | $25.72 | -21.6% |
| 76 | MEDP | MEDPACE HLDGS INC | Healthcare | 8,500.0 | $4.5M | 0.42% | NEW | — | $529.59 | +15.6% |
| 77 | MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | 8,050.0 | $4.3M | 0.41% | -16K | -66.5% | $536.95 | -4.4% |
| 78 | AMGN | AMGEN INC | Healthcare | 11,900.0 | $4.3M | 0.41% | -3K | -21.7% | $362.12 | +13.0% |
| 79 | SION | SIONNA THERAPEUTICS INC | Healthcare | 97,100.0 | $4.3M | 0.40% | +10K | +11.0% | $43.99 | -88.1% |
| 80 | — | ASCENDIS PHARMA A/S | — | 15,000.0 | $4.0M | 0.38% | NEW | — | $266.72 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Technology
0.4%